QQ
微信
| | 英文名称 | | 中文名称 | | CAS |
|---|---|---|
| Poziotinib (HM781-36B) | 波齐替尼 | 1092364-38-9 |
| Imipenem Impurity 3 | 亚胺培南杂质 3 | 130792-44-8 |
| pneumocandin C(0) | 卡泊芬净PNEUMOCANDIN CO杂质 | 144074-96-4 |
| ESAX-010 | 1632002-11-9 | 1632002-11-9 |
| Valdecoxib | 代他考昔 | 181695-72-7 |
| 3-Thiophenecarboxylic acid, 2-bromo-4-(trifluoromethyl)-, methyl ester Methyl 2-bromo-4-(trifluoromethyl)thiophene-3-carboxylate | 2-溴-4-(三氟甲基)噻吩-3-羧酸甲酯 | 1853236-69-7 |
| Protected Imipenem | 保护亚胺培南 | 98367-45-4 |
| (2S,3S)-1,2-Epoxy-3-(Boc-amino)-4-phenylbutane | 1-苄基-2,3-环氧正丙基-氨基甲酸叔丁酯 | 98737-29-2 |
| 6-bromo-7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridine | 6-溴-7,8-二甲基-[1,2,4]三唑并[1,5-A]吡啶 | 2171029-29-9 |
| ON-013100 | 865783-95-5 | 865783-95-5 |
| Glenzocimab | GLENZOCIMAB (格仑西单抗 ) | 2101829-58-5 |
| Relfovetmab | RELFOVETMAB (瑞弗维单抗 ) | 2171034-70-9 |
| Disitamab | DISITAMAB (迪西妥单抗 ) | 2185868-98-6 |
| Budigalimab | Budigalimab | 2098225-93-3 |
| Amatuximab | 阿麦妥单抗 | 931402-35-6 |
| Iladatuzumab | Iladatuzumab | 1906205-76-2 |
| Foralumab | FORALUMAB ( 福雷芦单抗 ) | 946415-64-1 |
| Lesofavumab | Lesofavumab | 1807960-57-1 |
| Pepinemab | PEPINEMAB (派比奈单抗 ) | 2097151-87-4 |
| Alacizumab Pegol | 培戈-阿拉赛珠单抗 | 934216-54-3 |
